MACH7 TECHNOLOGIES LIMITED — AGM Information 2021

Nov 10, 2021

==> picture [187 x 46] intentionally omitted <==

Mach7 Annual General Meeting

11 November 2021

==> picture [59 x 56] intentionally omitted <==

CEO PRESENTATION Mr Mike Lampron

==> picture [10 x 540] intentionally omitted <==

==> picture [371 x 33] intentionally omitted <==

==> picture [28 x 27] intentionally omitted <==

“Mach7” - who we are

==> picture [28 x 28] intentionally omitted <==

Our Solutions

==> picture [28 x 28] intentionally omitted <==

FY21 in Review FY22 so Far The Future

==> picture [28 x 28] intentionally omitted <==

==> picture [28 x 28] intentionally omitted <==

==> picture [25 x 6] intentionally omitted <==

==> picture [421 x 510] intentionally omitted <==

==> picture [960 x 374] intentionally omitted <==

----- Start of picture text -----

More than 150
customers spanning
15 countries
Hospitals and healthcare
entities around the world deploy
Mach7’s solutions and
innovative technologies.
We have built a global network
of diverse customers that range
from expansive Integrated
Delivery Networks, National
----- End of picture text -----

Hospital systems around the world use Mach7 Technologies

==> picture [10 x 540] intentionally omitted <==

==> picture [499 x 38] intentionally omitted <==

==> picture [320 x 38] intentionally omitted <==

An enterprise-wide, interoperable platform for storing, retrieving and viewing all medical imaging data in one vendor neutral ecosystem. Consisting of:

• Enterprise Data Management

• • Enterprise Diagnostic Viewing

• • Enterprise PACS

==> picture [307 x 520] intentionally omitted <==

At Mach7, we provide an Enterprise Imaging Platform, that provides:

==> picture [283 x 303] intentionally omitted <==

----- Start of picture text -----

Consolidation of all
images
At the core of this platform is a
Vendor Neutral Archive which
consolidates all images and
reports across the enterprise
into a single repository.
Removing redundant
operating expenses across an
enterprise.
----- End of picture text -----

==> picture [284 x 303] intentionally omitted <==

----- Start of picture text -----

Access all images
We then enable access to this
data to enterprise users
directly or through the
Electronic Medical Record
using our true zero footprint
viewer. This combined solution
insulates the enterprise users
from radiology departmental
technology changes or
departmental downtime
issues.
----- End of picture text -----

==> picture [283 x 303] intentionally omitted <==

----- Start of picture text -----

PACS solution
The enterprise platform can be
used as a diagnostic PACS
solution, research platform, or
AI integration platform without
impacting clinical workflow.
This is a software only solution
that leverages our customers
existing IT infrastructure to
streamline workflow and
reduce IT burden.
----- End of picture text -----

==> picture [10 x 540] intentionally omitted <==

==> picture [826 x 42] intentionally omitted <==

AI Current Market State

Mach7’s Visualization and Initiatives for AI

• Mach7 has partnership with Nuance Communications to empower AI within Radiology reading workflow to drive clinical outcomes

• AI is still maturing but has gained traction during pandemic especially in understanding COVID-19 to expedite drug discovery

• AI is set to play a more significant role in shaping future of imaging informatics.

• Nuance partnership is unique collaboration and innovative solution to accelerate adoption of AI models from the Nuance Marketplace within PowerScribe One by intelligently launching Mach7’s eUnity Diagnostic Viewer, pre-populating report with data produced by AI models. (Integrating AI in diagnostic workflows).

• AI requires Deep Learning from medical imaging data sets to guide and meet AI goals (e.g., predictive clinical decision support, analysis, detection, etc.)

Mach7 is continually looking to support the adoption and utilization of AI algorithms and models to improve clinical decision support, efficiencies, reduce costs and ultimately contribute to better patient outcomes. We are involved in several discovery projects with Partners and Customers to help in this goal.

• AI utilization and growth requires more seamless integration within core diagnostic reporting workflows.

• AI will need to be more closely integrated into existing imaging IT platforms to be of most use.

Mach7 is well known for its unique ability of allowing customers open access to their medical imaging data to create data sets for use in AI algorithms and models for clinical research and clinical use cases.

• In order to accommodate growing use of AI, we expect to see more focus on data management capabilities and data access.

• More value will be placed on Imaging IT platforms that allow greater access to data for increased exchange of more diverse information to drive AI clinical use cases and, increase adoption of AI algorithms.

• This includes connectivity of our VNA and workflow orchestration applications to the Cloud so that clinicians can use this data to apply AI algorithms and clinical protocols. We will continue to drive R&D to support this methodology.

Key Achievements FY21

M&A

Completed transformational acquisition of Client Outlook

Sales Up 95%

Achieved $25.6M of sales orders, highest in Mach7 history

ARR Up 80%

Grown CARR to $15.8M, with annualized ARR (current run rate) at $13.4M

New Talent

Steve Parkes, CFO

David Madaffri, VP Sales

Lisa Thompson, VP Services

Awards

==> picture [102 x 102] intentionally omitted <==

Frost & Sullivan

2021 Global Enterprise Imaging Solutions Product Leadership Award

==> picture [114 x 115] intentionally omitted <==

Industry Tech Insights

2021 Top 10 Companies Revolutionizing Healthcare

==> picture [118 x 118] intentionally omitted <==

CIO Review

2021 Top 20 Most Promising Workflow Solution Providers

==> picture [136 x 34] intentionally omitted <==

==> picture [44 x 34] intentionally omitted <==

==> picture [13 x 7] intentionally omitted <==

Impact to FY21

• Hospitals in the US faced unprecedented financial pressure

• This in turn effected hospital staffing and forced prioritization of projects

• Revenue delays were created by the timing of projects due to staffing and budget uncertainty

==> picture [109 x 105] intentionally omitted <==

Outlook FY22

• Hospital spending appears to be back on track

• Staffing issues are on their way to recovery

• Projects are being prioritized for imaging and IT

• Travel to sites and tradeshows will have a positive impact on pipeline

==> picture [309 x 488] intentionally omitted <==

• Sales orders $16.2M (TCV); up 368% on last quarter (Q4’21 $4.4M)

• Major expansion contract wins secured from Trinity Health and Advocate Aurora Healthcare

• Contracted annual recurring revenue (CARR) $16.8M; up 6% (or 24% annualized) (Q4’21 $15.8M)

• Cash on hand $18.5M; (30 June 2021 $18.4M)

*Total Contract Value (TCV) means software license fees, professional service fees and annual support

(or annual subscription) over the life of the contract.

==> picture [188 x 52] intentionally omitted <==

----- Start of picture text -----

Financial
----- End of picture text -----

==> picture [195 x 52] intentionally omitted <==

----- Start of picture text -----

Product
----- End of picture text -----

==> picture [195 x 52] intentionally omitted <==

----- Start of picture text -----

Sales & Marketing
----- End of picture text -----

==> picture [206 x 405] intentionally omitted <==

----- Start of picture text -----

Industry
Focused on Enterprise
Data Management, the
backbone of an
Enterprise Strategy
Focused on providing
the best enterprise
zero foot-print viewer
in the industry
Enterprise Imaging is
growing by segment in
the industry every year,
----- End of picture text -----

Organic Growth strategy

• Market transition from Radiology PACS focus to enterprise informatics focus. Mach7 VNA and Enterprise Viewer ideally suited for paradigm shift.

• Opportunity growth by 3[rd] party resellers of Mach7 solutions as they also focus on evolving enterprise informatics paradigm.

• Recruitment of highly skilled sales team has resulted in increased market visibility

and strong funnel growth.

• Portfolio cross selling opportunities increasing as a result of completed

integration of Client Outlook.

• Additional growth of recurring revenue from customers who reach “go live” on the Platform

Acquisitive Growth Strategy

• If we find opportunity that can fill product gaps and/or provide great value to our customers, we will evaluate that opportunity

• We are 100% committed to being cashflow positive into the future

• • Timing will be important as we feel undervalued in the market at present

==> picture [282 x 359] intentionally omitted <==

----- Start of picture text -----

We are opportunistic in
regards to acquisition and
100% committed to
remaining cashflow
positive on an annual
basis
----- End of picture text -----